ADMA Biologics, Inc.ADMANASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$110.10M
↑ 363% above average
Average (9y)
$-41.86M
Historical baseline
Range
High:$110.10M
Low:$-125.88M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $110.10M | +2782.9% |
| 2023 | $3.82M | +105.2% |
| 2022 | $-73.42M | +41.7% |
| 2021 | $-125.88M | -9.7% |
| 2020 | $-114.73M | -43.4% |
| 2019 | $-80.01M | -23.5% |
| 2018 | $-64.77M | -62.1% |
| 2017 | $-39.95M | -117.8% |
| 2016 | $-18.34M | -18.8% |
| 2015 | $-15.44M | - |